Wordt geladen...
Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease
PURPOSE: Infantile Pompe disease resulting from a deficiency of lysosomal acid α-glucosidase (GAA) requires enzyme replacement therapy (ERT) with recombinant human GAA (rhGAA). Cross-reactive immunologic material negative (CRIM-negative) Pompe patients develop high-titer antibody to the rhGAA and do...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3711224/ https://ncbi.nlm.nih.gov/pubmed/22237443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2011.4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|